64660-84-0

Basic information

• Product Name: cetyl myristoleate
• Synonyms: (Z)-hexadecyl tetradec-9-enoate;9-Tetradecenoic acid,hexadecyl ester, (9Z)-;NSC 275644;Cetyl-M;(9Z)-9-Tetradecenoic acid hexadecyl ester
• CAS NO: 64660-84-0
• Molecular Formula: C₃₀H₅₈O₂
• Molecular Weight: 450.78
• Mol File: 64660-84-0.mol
• Article Data: 2

Chemical Properties

• Boiling Point: 519.6°C at 760 mmHg
• Flash Point: 71.3°C
• Appearance: /
• Density: 0.865g/cm³
• Vapor Pressure: 6.75E-11mmHg at 25°C
• Refractive Index: 1.46
• CAS DataBase Reference: cetyl myristoleate(CAS DataBase Reference)
• NIST Chemistry Reference: cetyl myristoleate(64660-84-0)
• EPA Substance Registry System: cetyl myristoleate(64660-84-0)

Safety Data

• Hazardous Substances Data: 64660-84-0(Hazardous Substances Data)

Usage

Description

Cetyl Myristoleate is a chemical compound that is a type of fatty acid ester, more specifically a cetylated fatty acid (CFA). It is often derived from beef tallow or can also be found in the fats of other animals such as whales and beavers, as well as in certain types of nuts. It is commonly used as an ingredient in dietary supplements for its purported health benefits.

Uses

Used in Dietary Supplements:
Cetyl Myristoleate is used as a dietary supplement ingredient for its potential health benefits. Some research suggests that it may help in relieving pain and inflammation associated with conditions like arthritis and may support immune function. However, conclusive scientific evidence supporting these health benefits is lacking.
Used in Health and Wellness Industry:
In the health and wellness industry, cetyl myristoleate is used as a supplement ingredient for its purported benefits in managing joint pain and supporting the immune system. It is believed to have anti-inflammatory properties, which could potentially alleviate symptoms of arthritis and other inflammatory conditions. However, more research is needed to confirm these effects and establish the safety and efficacy of cetyl myristoleate supplementation.

InChI:InChI=1/C30H58O2/c1-3-5-7-9-11-13-15-16-17-19-21-23-25-27-29-32-30(31)28-26-24-22-20-18-14-12-10-8-6-4-2/h10,12H,3-9,11,13-29H2,1-2H3/b12-10+

Synthetic route

myristoleic acid (544-64-9) + 1-Hexadecanol (36653-82-4) → cis-9-cetyl myristoleate (64660-84-0)

Conditions	Yield
With toluene-4-sulfonic acid In benzene for 4h; Heating;	300 mg

Methyl oleate (112-62-9) → cis-9-cetyl myristoleate (64660-84-0)

Conditions	Yield
Multi-step reaction with 3 steps 1.1: ozone / dichloromethane / 1 h / -78 °C 1.2: 6 h / 25 °C 2.1: n-butyllithium / hexane; tetrahydrofuran / 0.5 h / 0 °C 2.2: 4 h / 0 - 25 °C / Reflux 3.1: Lipozyme TL 1M / 8 h / 68 °C / Enzymatic reaction View Scheme

1-Hexadecanol (36653-82-4) + myristoleic acid methyl ester (56219-06-8) → cis-9-cetyl myristoleate (64660-84-0)

Conditions	Yield
With Lipozyme TL 1M at 68℃; for 8h; Product distribution / selectivity; Enzymatic reaction;

methyl ester of azelaic acid aldehyde (1931-63-1) → cis-9-cetyl myristoleate (64660-84-0)

Conditions	Yield
Multi-step reaction with 2 steps 1.1: n-butyllithium / hexane; tetrahydrofuran / 0.5 h / 0 °C 1.2: 4 h / 0 - 25 °C / Reflux 2.1: Lipozyme TL 1M / 8 h / 68 °C / Enzymatic reaction View Scheme

cis-9-cetyl myristoleate (64660-84-0) → myristoleic acid (544-64-9) + 1-Hexadecanol (36653-82-4)

Conditions	Yield
With sodium hydroxide In water; acetone for 14h; Heating;	A 80% B 50%

cis-9-cetyl myristoleate (64660-84-0) → cetyl myristelaidate

Conditions	Yield
Multi-step reaction with 2 steps 1: 50 percent / 10percent NaOH / acetone; H2O / 14 h / Heating View Scheme

Upstream product

• 1931-63-1 methyl ester of azelaic acid aldehyde 
• 36653-82-4 1-Hexadecanol 
• 56219-06-8 myristoleic acid methyl ester 
• 112-62-9 Methyl oleate 
• 544-64-9 myristoleic acid 

Downstream Products

• 544-64-9 myristoleic acid 
• 36653-82-4 1-Hexadecanol 

Relevant articles and documents

Process for Preparation of Hexadecyl Cis-9-Tetradecenoate and Hexadecyl Cis-10-Tetradecenoate

Hexadecyl cis-9-tetradecenoate commonly known as Cetyl myristoleate (CMO) is being used for the treatment of osteoarthritis and other joint inflammatory diseases, cis-9-Tetradecenoic acid (cis-9-myristoleic acid) is the main precursor for the preparation of CMO. As there are limited natural plant sources for cis-9-tetradecenoic acid, the present invention aimed at the synthesis of cis-9-tetradecenoic acid methyl ester from oleic acid methyl ester. As oleic acid is not available in pure form, this has to be isolated from oleic acid-rich oils like olive oil. cis-10-Tetradecenoic acid methyl ester, an isomer of cis-9-tetradecenoic acid was also prepared from undecenoic acid methyl ester, a derivative of castor oil. Undecenoic acid is easily available commercially in pure form. Hexadecyl cis-9-tetradecenoate and hexadecyl c/s-10-tetradecenoate were prepared by enzymatic transesterification of cis-9-tetradecenoic acid methyl ester and cis-10-tetradecenoic acid methyl ester with 1-hexadecanol (cetyl alcohol) respectively. Both the isomers of cetyl myristoleate were evaluated for anti arthritis, blocking inflammation and reduction of adjuvant-induced arthritis in rats.